MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, ADCT made $20,851K in revenue. -$32,968K in net income. Net profit margin of -158.11%.

Income Overview

Revenue
$20,851K
Net Income
-$32,968K
Net Profit Margin
-158.11%
EPS
-$0.21
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product revenues, net
    • License revenues and royalties

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenue, net
20,851 23,058 16,427 18,839
Restructuring, impairment and other related costs
--348 377 13,091
Cost of product sales
3,615 1,699 1,202 836
Research and development
19,877 18,184 26,803 30,090
Selling and marketing
12,708 11,986 10,688 10,147
General and administrative
9,896 9,456 8,326 8,822
Total operating expense
46,096 40,977 47,396 62,986
Loss from operations
-25,245 -17,919 -30,969 -44,147
Interest income
1,994 2,352 2,470 1,934
Deferred royalty obligation interest expense
8,727 9,182 8,996 -
Effective interest expense on senior secured term loan facility
-3,829* --
Other interest expense
-3* --
Effective interest expense on senior secured term loan facility
3,622 -4,396 -
Interest expense
12,349 13,014 13,392 12,997
Other, net
2,632 21,768 925 -182
Total other expense, net
-7,723 11,106 -9,997 -11,245
Gain before income taxes
-32,968 -6,813 -40,966 -55,392
Income tax expense
0 -404 0 1,254
Loss before equity in net losses of joint venture
--6,409 -40,966 -56,646
Equity in net losses of joint venture
-0 0 0
Net loss
-32,968 -6,409 -40,966 -56,646
Basic EPS
-0.21 -0.042 -0.3 -0.5
Diluted EPS
-0.21 -0.042 -0.3 -0.5
Basic Average Shares
154,142,347 150,877,894 136,446,534 113,743,358
Diluted Average Shares
154,142,347 150,877,894 136,446,534 113,743,358
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$32,968K (14.60%↑ Y/Y)Gain before incometaxes-$32,968K Product revenues, net$20,033K (15.11%↑ Y/Y)License revenues androyalties$818K (-85.47%↓ Y/Y)Loss from operations-$25,245K (11.31%↑ Y/Y)Total other expense,net-$7,723K (22.56%↑ Y/Y)Total revenue, net$20,851K (-9.47%↓ Y/Y)Other, net$2,632K (1196.55%↑ Y/Y)Interest income$1,994K (-2.92%↓ Y/Y)Total operatingexpense$46,096K (-10.49%↓ Y/Y)Interest expense$12,349K (0.97%↑ Y/Y)Research and development$19,877K (-31.29%↓ Y/Y)Selling and marketing$12,708K (20.42%↑ Y/Y)General andadministrative$9,896K (-0.59%↓ Y/Y)Cost of product sales$3,615K (75.40%↑ Y/Y)Deferred royaltyobligation interest...$8,727K (3.34%↑ Y/Y)Effective interestexpense on senior...$3,622K (-4.31%↓ Y/Y)

ADC Therapeutics SA (ADCT)

ADC Therapeutics SA (ADCT)